Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
3D reconstruction of human liver tissue at cellular resolution.
Journal: Science advances
Published: February 18, 2026
Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
Journal: Hepatology (Baltimore, Md.)
Published: October 31, 2025
Intravascular Hepatocyte Lipid Droplets Are Commonly Present in Hepatic Sinusoids, Portal Venules, and Central Veins in MASH.
Journal: Gastro hep advances
Published: September 09, 2025
Development of an AI algorithm for early identification of MASLD in the electronic health record.
Journal: Hepatology communications
Published: June 13, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations.
Journal: The Journal of clinical investigation
Published: April 01, 2025
Soluble TREM2 is a biomarker but not a mediator of fibrosing steatohepatitis.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025
LiverMap pipeline for 3D imaging of human liver reveals volumetric spatial dysregulation of cirrhotic vasculobiliary architecture.
Journal: bioRxiv : the preprint server for biology
Published: September 30, 2024
Hepatologist Consultation in Low-Risk MASLD.
Journal: The New England journal of medicine
Published: July 24, 2024
Final Search for Short-Baseline Neutrino Oscillations with the PROSPECT-I Detector at HFIR.
Journal: Physical review letters
Published: July 03, 2024
Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems.
Journal: Clinical and translational science
Published: June 14, 2024
Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases.
Journal: Seminars in liver disease
Published: October 06, 2023
Last Updated: 09/26/2026